HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

macitentan

structure in first source
Also Known As:
ACT 064992; ACT-064992; ACT064992; Actelion-1; N-(5-(4-bromophenyl)-6-(2-(5-bromopyrimidin-2-yloxy)ethoxy)pyrimidin-4-yl)-N'-propylaminosulfonamide; opsumit
Networked: 246 relevant articles (26 outcomes, 59 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Dingemanse, Jasper: 14 articles (01/2018 - 03/2012)
2. Sitbon, Olivier: 13 articles (01/2022 - 08/2013)
3. Sidharta, Patricia N: 13 articles (01/2017 - 03/2012)
4. Channick, Richard N: 12 articles (01/2022 - 08/2013)
5. Pulido, Tomás: 12 articles (01/2022 - 08/2013)
6. Simonneau, Gérald: 12 articles (01/2022 - 08/2013)
7. Bagnato, Anna: 10 articles (04/2022 - 12/2014)
8. Delcroix, Marion: 10 articles (01/2022 - 08/2013)
9. Galiè, Nazzareno: 10 articles (01/2022 - 08/2013)
10. Iglarz, Marc: 10 articles (10/2020 - 12/2008)

Related Diseases

1. Pulmonary Arterial Hypertension
2. Pulmonary Hypertension
3. Hypertrophy
4. Neoplasms (Cancer)
5. Hypertension (High Blood Pressure)

Related Drugs and Biologics

1. Endothelin Receptor Antagonists
2. Bosentan (Tracleer)
3. ambrisentan
4. Endothelins (Endothelin)
5. Endothelin Receptors (Endothelin Receptor)
6. Paclitaxel (Taxol)
7. selexipag
8. riociguat
9. Tadalafil (Cialis)
10. Temozolomide (Temodar)

Related Therapies and Procedures

1. Therapeutics
2. Liver Transplantation
3. Aftercare (After-Treatment)
4. Drug Therapy (Chemotherapy)
5. Artificial Respiration (Mechanical Ventilation)